In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk

Authors: Amber O. Molnar,

Published: 2025-06-02

DOI: 10.7326/annals-25-01947-jc

Source: Full article

Abstract

No abstract found.